Jim Simons Vanda Pharmaceuticals Inc. Transaction History
Renaissance Technologies LLC
- $56.7 Billion
- Q2 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 4,114,125 shares of VNDA stock, worth $20.7 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
4,114,125
Previous 4,275,625
3.78%
Holding current value
$20.7 Million
Previous $17.6 Million
32.27%
% of portfolio
0.04%
Previous 0.03%
Shares
23 transactions
Others Institutions Holding VNDA
# of Institutions
153Shares Held
44.9MCall Options Held
132KPut Options Held
220K-
Black Rock Inc. New York, NY8.14MShares$40.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.43MShares$17.2 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.26MShares$11.4 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.15MShares$10.8 Million1.49% of portfolio
-
Acadian Asset Management LLC Boston, MA1.98MShares$9.95 Million0.03% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $284M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...